Plant ID: NPO21139
Plant Latin Name: Daphniphyllum calycinum
Taxonomy Genus: Daphniphyllum
Taxonomy Family: Daphniphyllaceae
NCBI TaxonomyDB:
182071
Plant-of-the-World-Online:
n.a.
China
TSHR; | |
GPBAR1; | |
PTPN1; PTPN2; CDC25B; | |
PLA2G1B; AKR1B10; ALDH1A1; POLB; | |
PRKCA; CDK8; CDK9; | |
NR1H4; | |
HIF1A; | |
NPC1; RAB9A; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | PLA2G1B | Phospholipase A2 group 1B | P04054 | CHEMBL4426 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | PRKCA | Protein kinase C alpha | P17252 | CHEMBL299 |
Protein Kinase | CDK8 | Cell division protein kinase 8 | P49336 | CHEMBL5719 |
Protein Kinase | CDK9 | Cyclin-dependent kinase 9 | P50750 | CHEMBL3116 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Protein Phosphatase | PTPN2 | T-cell protein-tyrosine phosphatase | P17706 | CHEMBL3807 |
Protein Phosphatase | CDC25B | Dual specificity phosphatase Cdc25B | P30305 | CHEMBL4804 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 2.952E-13 | 3.214E-09 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 8.200E-12 | 3.571E-08 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.889E-11 | 6.857E-08 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 2.365E-11 | 7.356E-08 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 6.207E-10 | 1.690E-06 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 5.125E-09 | 7.005E-06 | CYP1A2, CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0020037; heme binding | 5.147E-09 | 7.005E-06 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 1.101E-08 | 1.262E-05 | CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.966E-08 | 1.861E-05 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 2.802E-07 | 1.907E-04 | CYP1A2, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 2.238E-06 | 1.133E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0001523; retinoid metabolic process | 3.023E-06 | 1.463E-03 | AKR1B10, ALDH1A1, CYP1A1, CYP1B1 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 3.712E-06 | 1.645E-03 | GPBAR1, NR1H4 |
MF | GO:0003824; catalytic activity | GO:0070576; vitamin D 24-hydroxylase activity | 3.712E-06 | 1.645E-03 | CYP1A1, CYP3A4 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 3.712E-06 | 1.645E-03 | GPBAR1, NR1H4 |
BP | GO:0009987; cellular process | GO:1902202; regulation of hepatocyte growth factor receptor signaling pathway | 7.420E-06 | 2.992E-03 | PTPN1, PTPN2 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 7.420E-06 | 2.992E-03 | CYP1A1, CYP1A2 |
MF | GO:0005488; binding | GO:0019899; enzyme binding | 8.188E-06 | 3.184E-03 | CDC25B, CDK9, CYP1A1, CYP1A2, CYP2C19, CYP3A4, HIF1A, POLB, PRKCA, PTPN1, PTPN2 |
BP | GO:0008152; metabolic process | GO:0016042; lipid catabolic process | 1.115E-05 | 4.184E-03 | AKR1B10, CYP1A2, CYP1B1, CYP3A4, PLA2G1B |
MF | GO:0003824; catalytic activity | GO:0101020; estrogen 16-alpha-hydroxylase activity | 1.236E-05 | 4.498E-03 | CYP1A1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0002933; lipid hydroxylation | 1.852E-05 | 6.210E-03 | CYP1A1, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0046626; regulation of insulin receptor signaling pathway | 2.284E-05 | 7.534E-03 | NR1H4, PTPN1, PTPN2 |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 2.591E-05 | 8.298E-03 | CYP1A2, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0001758; retinal dehydrogenase activity | 2.591E-05 | 8.298E-03 | AKR1B10, ALDH1A1 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 4.972E-05 | 1.406E-02 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9, CYP3A4, RAB9A |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.154E-10 | 1.130E-08 | CYP2C9, PLA2G1B, CYP1A2, CYP3A4, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.792E-10 | 1.368E-08 | CYP2C9, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 7.821E-09 | 2.555E-07 | CYP2C9, CYP1A2, ALDH1A1, CYP1A1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.414E-08 | 3.465E-07 | CYP2C9, CYP1A2, CYP1A1, CYP1B1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 9.054E-07 | 1.479E-05 | CYP2C9, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 4.479E-07 | 8.779E-06 | CYP1A2, CYP1A1, CYP1B1, CYP3A4 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 1.112E-05 | 1.556E-04 | CYP1A2, CYP1A1, CYP1B1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 3.100E-05 | 3.797E-04 | CYP2C9, AKR1B10, PLA2G1B, CYP1A2, ALDH1A1, CYP1A1, CYP2C19, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 4.189E-05 | 4.561E-04 | CYP2C9, PLA2G1B, CYP2C19 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 2.436E-04 | 2.387E-03 | CYP2C9, PRKCA, CYP2C19 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Pulmonary arterial hypertension | I27.0, I27.2 | HIF1A; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | HIF1A; |
C00-D49: Neoplasms | Cancer | C00-C96 | HIF1A; CDC25B; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | HIF1A; |